Our results confirm the overexpression of TYMS in this population and suggest that assessment of TYMS gene-expression levels by qPCR may be of predictive value when assesing sensitivity to pemetrexed-based chemotherapy in NSCLC. This evidence concerns the gene TYMS and non-small cell lung carcinoma.